Approval · Notice of Compliance 37319 · 2026
NEFFY: Notice of Compliance 37319
Issued April 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37319
- Date
- April 9, 2026
- Company
- Alk-Abello IncPort Washington, New York, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEFFY | 02567121 | Marketed |
Medicinal ingredients
- EPINEPHRINE 2 MG per 0.1ML